Search

Transportation Asset Management (TAM) is a data-driven decision-making process to maintain and extend the serviceability of transportation assets throughout their lifecycle. TAM is an extensive data process that requires accurate and high-quality information for better decision-making. A significant challenge faced by state Departments of Transportation (DOTs) is the need to allocate their limited funds to optimize their assets' performance. The criticality of this challenge increases when state DOTs need to manage a wide variety of assets distributed along with a vast network. To address this challenge, a new paradigm of digitizing the management of the built environment is emerging and is perceived to highly depend on the integration of several technologies namely on Digital Twins. Digital Twins, by definition, are the connection between the physical and the digital aspects of an asset, thus, aligning with the overarching objective of asset management of leveraging the use of the asset information (i.e., digital aspect of the asset) to improve the asset's performance throughout its lifecycle (i.e., physical aspect of the asset). At the core of implementing Digital Twins is having the right data collected for use throughout the lifecycle of the asset. Thus, realizing the potentials of Digital Twins in supporting state DOTs to manage their transportation assets and the anticipated benefits, this paper investigated the current practices of state DOTs in digitizing the Data Collection for Roadside Asset Systems by developing and distributing a web-based survey. Five major Data Collection variables and seven Roadside Asset Systems were considered. Furthermore, this paper presents a case study from a leading DOT in digitizing the management of the built environment to further understand the requirements of implementing Digital Twins to support transportation asset data management. [ABSTRACT FROM AUTHOR]

Objectives: The aim of the study was to assess the interest to combine cytological examination and human papillomavirus (HPV) typing of anal and cervical Papanicolaou (Pap) smears of HIV‐infected patients on combination antiretroviral therapy (cART), to evaluate whether differences in prevalence exist between anal and cervical squamous intraepithelial lesions in patients with high‐risk oncogenic HPV infection. Methods: Anal and/or cervical Pap smears were obtained by anoscopy and/or colposcopy in 238 subjects recruited consecutively in 2015: anal smears were obtained from 48 male and female patients [42 men; 35 men who have sex with men (MSM)] and cervical smears from 190 female patients. Cytological Bethesda classification was coupled with HPV typing. HPV typing was performed, on the same smears, using the Xpert®HPV Assay, which detects only high‐risk HPV (hrHPV), and the Anyplex®II HPV28 Detection assay, which detects hrHPV and low‐risk (lr) HPV. Results: Our data showed clear‐cut differences between the anal and cervical samples. Compared with the cervical samples, the anal samples exhibited (1) more numerous cytological lesions, which were histologically proven; (2) a higher hrHPV infection prevalence; (3) a higher prevalence of multiple hrHPV coinfections whatever HPV typing kit was used; (4) a predominance of HPV16 and HPV18/45 types. Overall, there was an almost perfect agreement between the two HPV typing assays (absolute agreement = 90.3%). Conclusions: Co‐testing consisting of cytology and HPV typing is a useful screening tool in the HIV‐infected population on cART. It allows detection of prevalence differences between anal and cervical HPV‐related lesions. As recently recommended, anal examination should be regularly performed especially in HIV‐infected MSM but also in HIV‐infected women with genital hrHPV lesions. [ABSTRACT FROM AUTHOR]